Open AccessAn overview of serum prostatic surface antigen cut points for recommendation of prostatic biopsy
Author(s) -
Sujata Patwardhan,
Bhushan Patil,
Umesh Ravikant Shelke,
Abhishek Singh
Publication year - 2018
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/ua.ua_113_17
Subject(s) - medicine , biopsy , urology , prostate specific antigen , prostatic diseases , prostate , pathology , cancer
Patients in India frequently present with prostatic surface antigen (PSA) report and request for prostatic biopsy to rule out malignancy. With fear of harboring malignancy set in patient's mind, it becomes difficult to counsel them about absolute indications and need of biopsy. Whether serum PSA has same predictability in symptomatic patients in the Indian context for advising prostatic biopsy at same reference ranges as in western countries, remains to be answered.